ROBB GARY CHARLES (Chief Business Officer) reported 3 transactions at CORCEPT THERAPEUTICS INC
Review the transaction codes below to understand the nature of each event.
Filed: 8/14/2026ACC: 0001193125-26-352428
Officer· Chief Business Officer
Since Mar 2026
-5.53K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
6K acquired · 11.53K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−11.53K
Price / share
—
Trade value
—
% of position
46.0%
8/12/2026
25.08K→13.55K
Common Stock
Indirect
Shares
+3K
Price / share
—
Trade value
—
% of position
23.9%
8/12/2026
12.57K→15.57K
Common Stock
Indirect
Shares
+3K
Price / share
—
Trade value
—
% of position
23.9%
8/12/2026
12.57K→15.57K
Total
Net shares
−5.53K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/12/2026 | G · Gift | −11.53K | — | — | 46.0% | 25.08K | 13.55K |
| Common Stock Indirect | 8/12/2026 | G · Gift | +3K | — | — | 23.9% | 12.57K | 15.57K |
| Common Stock Indirect | 8/12/2026 | G · Gift | +3K | — | — | 23.9% | 12.57K | 15.57K |
| Total | −5.53K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned49.72K
Total
49.72K indirect49.72K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 49.72K | Indirect |
| Total | 49.72K | 49.72K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported